KRT14 anticorps

N° du produit ABIN7180977

L’anticorps Souris Monoclonal anti-KRT14 a été validé pour IHC et ELISA. Il convient pour détecter KRT14 dans des échantillons de Humain.

Aperçu rapide pour KRT14 anticorps (ABIN7180977)

Antigène: KRT14 (Keratin 14 (KRT14))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp KRT14 est non-conjugé

Application: Immunohistochemistry (IHC), ELISA

Détail du produit anti-KRT14 anticorps

Fonction: KRT14/KRT16/KRT5/KRT6A/KRT8 Monoclonal Antibody

Purification: The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.

Immunogène: Synthesized peptide derived from human Cytokeratin Pan

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur KRT14

Antigène: KRT14 (Keratin 14 (KRT14))

Autre désignation: KRT14

Sujet:

Background: Cytokeratin pan is part of a subfamily of intermediate filament proteins that are characterized by remarkable biochemical diversity, and represented in human epithelial tissues by at least 20 different polypeptides. Cytokeratins range in molecular weight between 40 kDa- 68 kDa, and an isoelectric pH between 4.9-7.8. The individual human cytokeratins are numbered 1 to 20. The various epithelia in the human body usually express cytokeratins which are not only characteristic of the type of epithelium, but also related to the degree of maturation or differentiation within an epithelium. Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays. The composition of cytokeratin pairs vary with the epithelial cell type, stage of differentiation, cellular growth environment, and disease state. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis.

Aliases: CARD2, CK-4, CK-6C, CK-6E, CK-8, CK14, CK16, CK4, CK5, CK6A, CK6C, CK6D, CK8, CYK4, CYK8, DDD, DDD1, EBS2, EBS3, EBS4, FNEPPK, K14, K16, K1CP, K2C8, K4, K5, K6A, K6C, K6D, K8, KO, KRT14, KRT16, KRT16A, KRT5, KRT5A, KRT6A, KRT6C, KRT6D, KRT8, NEPPK, NFJ, PC1, PC3, WSN1, 58 kDa cytokeratin, CK-14, CK-16, CK-5, CK-6A, CK-6D, CK-8, cytokeratin 14, cytokeratin 16, cytokeratin 4, cytokeratin 6A, cytokeratin 6C, cytokeratin 6D, Cytokeratin-14, Cytokeratin-16, Cytokeratin-5, Cytokeratin-6A, cytokeratin-6C, Cytokeratin-6D, cytokeratin-6E, Cytokeratin-8, epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types, focal non-epidermolytic palmoplantar keratoderma, Hom s 5, K14, K16, K5, K6A, K8, kamp-keratin derived antimicrobial peptide, KDAMP, keratin 14, type I, keratin 16, type I, keratin 4, type II, keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types), keratin 5, type II, keratin 6A, , type II, keratin 6A, type II, keratin 8, type II, keratin K6h, keratin, epidermal type II, K6A, Keratin, type I cytoskeletal 14, Keratin, type I cytoskeletal 16, Keratin, type II cytoskeletal 5, Keratin, type II cytoskeletal 6A, Keratin, type II cytoskeletal 8, Keratin-14, Keratin-16, Keratin-5, Keratin-6A, keratin-6C, Keratin-8, pankeratin, type-II keratin Kb12, type-II keratin Kb4, Type-II keratin Kb5, Type-II keratin Kb6, Type-II keratin Kb8

UniProt: P02533, P08779, P13647, P02538, P05787